variable | GPS 0 | GPS 1 | GPS 2 | P Value | ||||
---|---|---|---|---|---|---|---|---|
(N = 409) | (N = 117) | (N = 68) | ||||||
Age | (years) | 0.046 | ||||||
< 75 | 290 | 48.8% | 81 | 13.6% | 38 | 6.4% | ||
≥75 | 119 | 20.0% | 36 | 19.7% | 30 | 11.4% | ||
Sex | 0.075 | |||||||
female | 168 | 28.3% | 35 | 5.9% | 29 | 4.9% | ||
male | 241 | 40.6% | 117 | 19.7% | 68 | 11.4% | ||
BMI | 0.039 | |||||||
≥18.5 | 328 | 58.5% | 108 | 19.3% | 54 | 9.6% | ||
< 18.5 | 48 | 8.6% | 9 | 1.6% | 14 | 2.5% | ||
tumor location | 0.008 | |||||||
right side | 159 | 26.8% | 60 | 10.1% | 37 | 6.2% | ||
left side | 250 | 42.1% | 57 | 9.6% | 31 | 5.2% | ||
opearation approach | 0.02 | |||||||
open | 236 | 39.8% | 80 | 13.5% | 49 | 8.3% | ||
lap | 172 | 29.0% | 37 | 6.2% | 19 | 3.2% | ||
Tumor size | (cm) | < 0.001 | ||||||
< 5 | 279 | 48.4% | 52 | 9.0% | 16 | 2.8% | ||
≥5 | 118 | 20.5% | 60 | 10.4% | 51 | 8.9% | ||
T | 0.011 | |||||||
T2/3 | 342 | 57.6% | 99 | 16.7% | 47 | 7.9% | ||
T4 | 67 | 11.3% | 18 | 3.0% | 21 | 3.5% | ||
N | 0.016 | |||||||
N0 | 196 | 33.1% | 67 | 11.3% | 44 | 7.4% | ||
N1/2/3 | 213 | 35.8% | 50 | 8.4% | 24 | 4.0% | ||
CEA | (ng/ml) | 0.361 | ||||||
< 5 | 263 | 49.0% | 69 | 12.8% | 39 | 7.3% | ||
≥5 | 108 | 20.1% | 35 | 6.5% | 23 | 4.3% | ||
CA19–9 | (U/ml) | 0.588 | ||||||
< 37 | 302 | 56.5% | 83 | 15.5% | 43 | 8.1% | ||
≥37 | 74 | 13.9% | 18 | 3.4% | 14 | 2.6% |